These medtech companies raised the most VC last year

4 (tied). PulmonX

Redwood City, Calif.
Venture capital raised: $50 million

PulmonX raised $50 million in venture capital during its later stage of development in the second quarter of 2017, according to the MoneyTree Report. This marks the company’s sixth investment sequence. Venture capital investors include De Novo Ventures, HealthCap Venture Capital, Kleiner Perkins Caufield & Byers, Latterell Venture Partners and Montreux Equity Partners.

PulmonX develops an endoscopic lung volume reduction (ELVR) device, known as the Zephyr Endobronchial Valve, for patients with emphysema-induced hyperinflation. The company also developed the Chartis System as an assessment tool for identifying collateral ventilation. Its StratX Lung Analysis Platform is a cloud-based quantitative computed tomography (CT) analysis service.

Next >>

Only a Few More Days to Register for the most anticipated conference of the winter! DeviceTalks West is just a few days away. Join more than 300 of your peers for a day of world-class education, networking, and a technology exhibition featuring the leading companies in the industry. Don’t miss out on this premier opportunity to come together and share perspectives with the best of the best in the industry. REGISTER NOW Use code LASTCHANCE to save an additional 20%.